[
  {
    "patient_ID": "TCGA.D3.A1Q1",
    "drug_therapy_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 341,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A1Q1",
    "pharmaceutical_therapy_type": "MELANOMA-DERIVED HELPER PEPTIDES",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 341,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A1Q1",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 341,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A1Q3",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 362,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 362,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A1Q6",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 476,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A1Q9",
    "drug_therapy_name": "LEUPROLIDE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A1Q9",
    "drug_therapy_name": "GP-100",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A1QA",
    "drug_therapy_name": "RECMAGE3",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 1485,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1538,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A2JC",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 415,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A2JH",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 321,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A2JL",
    "drug_therapy_name": "GP-100",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 2552,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2911,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A2JL",
    "drug_therapy_name": "RECMAGE3",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 2552,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2911,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A2JN",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 123,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A2JP",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A3C1",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A3C7",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 488,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A3CB",
    "drug_therapy_name": "MEL-44",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 2716,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3079,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A3MV",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 572,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 639,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51E",
    "drug_therapy_name": "DACTINOMYCIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2506,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2506,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51E",
    "drug_therapy_name": "MELPHALAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2506,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2506,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51G",
    "drug_therapy_name": "MELPHALAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51G",
    "drug_therapy_name": "DACTINOMYCIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51G",
    "drug_therapy_name": "GP-100",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A51G",
    "drug_therapy_name": "RESIQUIMOD",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D3.A51H",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 894,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1045,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51H",
    "drug_therapy_name": "VINBLASTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 894,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1045,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A51H",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 894,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1045,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A5GT",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A8GB",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 318,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A8GK",
    "drug_therapy_name": "MEL-44",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 2060,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2425,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.D3.A8GN",
    "pharmaceutical_therapy_type": "CANCERVAX",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1224,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1639,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.D9.A148",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 4426,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4496,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "patient_ID": "TCGA.DA.A1I1",
    "drug_therapy_name": "PEMBROLIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 6607,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DA.A3F2",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 475,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 772,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.DA.A3F5",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 6830,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 6869,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.DA.A3F5",
    "drug_therapy_name": "PEMBROLIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 6660,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 6814,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 203,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "INTERFERON ALFA 2B",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 203,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 203,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 547,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 632,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "INTERFERON ALFA 2B",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 559,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 559,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24C",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 517,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24D",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 41,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24D",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 645,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24D",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 567,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 582,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A24D",
    "drug_therapy_name": "ALFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 645,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A3XC",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 410,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 558,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A3Y6",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 126,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A4OY",
    "drug_therapy_name": "TOREMIFENE",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A4OY",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A550",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A553",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A553",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 115,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "VINBLASTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "ONDANSETRON",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "ERYTHROPOIETIN",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "CYCLOSPORIN",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A57M",
    "drug_therapy_name": "RENAMIN",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5FP",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 52,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5FP",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 52,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5KH",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 557,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 615,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5KH",
    "drug_therapy_name": "VINBLASTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 557,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 615,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5KH",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 557,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 615,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5KH",
    "drug_therapy_name": "SARGRAMOSTIM",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 557,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 615,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5SH",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1091,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5SH",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1091,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1125,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5SH",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1154,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1217,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5UL",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 280,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5UL",
    "drug_therapy_name": "VINBLASTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 280,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A5UL",
    "drug_therapy_name": "BLEOMYCIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 280,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A6QY",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A6QY",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A6QY",
    "drug_therapy_name": "INTERFERON ALFA 2B",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A6QZ",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 244,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A6QZ",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 244,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A6R0",
    "drug_therapy_name": "LOMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A85J",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EB.A85J",
    "drug_therapy_name": "VINCRISTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A182",
    "drug_therapy_name": "PV-10",
    "pharmaceutical_therapy_type.1": "ANCILLARY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 329,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A185",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 126,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29C",
    "drug_therapy_name": "PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 439,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 620,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A29C",
    "drug_therapy_name": "BRAF INHIBITOR;GSK INHIBITOR",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1114,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1502,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A29C",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1500,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1623,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29C",
    "drug_therapy_name": "DABRAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2262,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2413,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29C",
    "drug_therapy_name": "TRAMETINIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2262,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2413,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29H",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 895,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A29H",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 895,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1231,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A29H",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1294,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29Q",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1837,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1858,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29T",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 11015,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29V",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 715,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 787,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A29X",
    "drug_therapy_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 517,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 517,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2A5",
    "drug_therapy_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1142,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1142,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2GH",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 4948,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GH",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 4948,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 5753,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GI",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 642,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GI",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 642,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1393,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GL",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 1421,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GL",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 1421,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2093,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GS",
    "drug_therapy_name": "DABRAFENIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1596,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1978,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GS",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1979,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2075,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2GS",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2127,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GS",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2257,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2354,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2GS",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2372,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2GU",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 1855,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2609,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2M5",
    "drug_therapy_name": "PNU-159548",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 559,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 559,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2M6",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 992,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2763,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2MD",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1377,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1408,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2ME",
    "drug_therapy_name": "CANCER VAX",
    "pharmaceutical_therapy_type": "CANCERVAX",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 2296,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2933,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2MG",
    "drug_therapy_name": "CANCER VAX",
    "pharmaceutical_therapy_type": "CANCERVAX",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 1837,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2585,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2MG",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 2764,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2932,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2MH",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 429,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2ML",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 5973,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 6156,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2ML",
    "drug_therapy_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 6279,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 6339,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2ML",
    "drug_therapy_name": "MORAB-004",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 6355,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 6440,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A2MM",
    "drug_therapy_name": "VMCL",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 3636,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4328,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2MM",
    "drug_therapy_name": "AUTOLOGOUS VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 4412,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4618,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2MN",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1290,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1338,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A2MQ",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1176,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1207,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A3AA",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing": false,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A3AD",
    "drug_therapy_name": "BRAF INHIBITOR",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 632,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE"
  },
  {
    "patient_ID": "TCGA.EE.A3AE",
    "drug_therapy_name": "RECMAGE3",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 804,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1574,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A3AF",
    "drug_therapy_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 404,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A3AG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A3AG",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A3AH",
    "drug_therapy_name": "MUPARFOSTAT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3977,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4104,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.EE.A3JB",
    "drug_therapy_name": "ALFERON",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 24,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A3JI",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4529,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 4571,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.EE.A3JI",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 4608,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.ER.A195",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 562,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 911,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A198",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 426,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 517,
    "drug_units": "MG",
    "drug_dose": 400,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A19E",
    "drug_therapy_name": "PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 257,
    "drug_cycles": 2,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A19E",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 257,
    "drug_cycles": 2,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A19G",
    "drug_therapy_name": "SARGRAMOSTIM",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 4740,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 5013,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A19H",
    "drug_therapy_name": "PATRIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3716,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A19H",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3627,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3716,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.ER.A19J",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 119,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A19K",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 388,
    "drug_cycles": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A19M",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1019,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1093,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.ER.A19N",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing": false,
    "drug_cycles": 4,
    "drug_dose": 20,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A19O",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A19Q",
    "drug_therapy_name": "IL-18",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1274,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1337,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_dose": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A19Q",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1394,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1428,
    "drug_cycles": 1,
    "drug_units": "G/DAY",
    "drug_dose": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A1A1",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 418,
    "drug_route": "INTRAVENOUS;SUBCUTANEOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A2NC",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1278,
    "pharmaceutical_tx_ongoing": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A2NF",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 136,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.ER.A2NF",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 471,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 502,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A2NF",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 471,
    "pharmaceutical_tx_ongoing": true,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A2NG",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 705,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 766,
    "drug_cycles": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A2NG",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 889,
    "pharmaceutical_tx_ongoing": true,
    "drug_units": "MG",
    "drug_dose": 480,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A2NG",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 609,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "patient_ID": "TCGA.ER.A3EV",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 366,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 366,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A2OS",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 311,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 368,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "patient_ID": "TCGA.FR.A3YN",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2324,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2387,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A3YO",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FR.A44A",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2769,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FR.A69P",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A728",
    "drug_therapy_name": "DABRAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A728",
    "drug_therapy_name": "TRAMETINIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A729",
    "drug_therapy_name": "SYLATRON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 6253,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FR.A7U8",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A7U9",
    "drug_therapy_name": "T-VEC",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A7U9",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A8YC",
    "drug_therapy_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1020,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1020,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FR.A8YD",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 812,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 880,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A1ZE",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 651,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 761,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FS.A1ZE",
    "drug_therapy_name": "PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 762,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 853,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FS.A1ZE",
    "drug_therapy_name": "ANGIOCAL",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 896,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1034,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FS.A1ZE",
    "drug_therapy_name": "CARBOPLATIN;PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1188,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A1ZE",
    "drug_therapy_name": "CARBOPLATIN;PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1188,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A1ZS",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2566,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2790,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A1ZT",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 398,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1053,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A1ZW",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 700,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1005,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A4F0",
    "drug_therapy_name": "TREOSULFAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1543,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1603,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FS.A4F0",
    "drug_therapy_name": "INTERFERON ALFA",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 568,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A4F0",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1359,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1521,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FS.A4F0",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1543,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1603,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.FS.A4F9",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1035,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FW.A3R5",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 714,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 993,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FW.A3TV",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 58,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.FW.A3TV",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GF.A3OT",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GF.A3OT",
    "drug_therapy_name": "PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GF.A3OT",
    "drug_therapy_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GF.A3OT",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A264",
    "drug_therapy_name": "INTERFERON ALFA 2B",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2752,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3111,
    "regimen_number": 1,
    "drug_route": "SUBCUTANEOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "patient_ID": "TCGA.GN.A267",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1520,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1530,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "patient_ID": "TCGA.GN.A26D",
    "pharmaceutical_therapy_type.1": "OTHER",
    "days_to_drug_start": 757,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 757,
    "pharma_type_other": "ISOLATED LIMB PERFUSION (ILP)",
    "regimen_number": 1,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "AT SAME TIME AS SURGERY"
  },
  {
    "patient_ID": "TCGA.GN.A4U3",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2299,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2574,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U4",
    "drug_therapy_name": "AXITINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 245,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 647,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.GN.A4U4",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 637,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 707,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U5",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 435,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U7",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U8",
    "drug_therapy_name": "SYLATRON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1186,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U9",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 249,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U9",
    "drug_therapy_name": "MELPHALAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 60,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U9",
    "drug_therapy_name": "IMIQUIMOD",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A4U9",
    "drug_therapy_name": "AXITINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 523,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 579,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.GN.A8LK",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1248,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1269,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A8LK",
    "drug_therapy_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1493,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1513,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A8LK",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1407,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1428,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.GN.A8LN",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 464,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 464,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A8LN",
    "drug_therapy_name": "CARBOPLATIN",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A8LN",
    "drug_therapy_name": "PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A8LN",
    "drug_therapy_name": "PEMBROLIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 772,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A9SD",
    "drug_therapy_name": "DACTINOMYCIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1268,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1268,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A9SD",
    "drug_therapy_name": "MELPHALAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1366,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1366,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A9SD",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1519,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1687,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.GN.A9SD",
    "drug_therapy_name": "MELPHALAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1268,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1268,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HR.A2OH",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 471,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HR.A2OH",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1729,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1753,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.HR.A2OH",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1830,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1848,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.QB.AA9O",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 234,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A824",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1491,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2710,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.A825",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1644,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1767,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A825",
    "drug_therapy_name": "VINBLASTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1644,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1767,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A825",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1644,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1767,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A825",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1644,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1767,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A825",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1644,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1767,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A825",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1644,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1767,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.A828",
    "pharmaceutical_therapy_type": "BIOLOGICAL THERAPY",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1887,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2283,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1O",
    "drug_therapy_name": "CARMUSTINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA1O",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA1O",
    "drug_therapy_name": "CISPLATIN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA1O",
    "drug_therapy_name": "DACARBAZINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA1Q",
    "drug_therapy_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type.1": "HORMONE THERAPY",
    "days_to_drug_start": 1735,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1Q",
    "drug_therapy_name": "TRASTUZUMAB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1735,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1Q",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1492,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA1Q",
    "pharmaceutical_therapy_type": "BIOLOGICAL THERAPY",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1735,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1Q",
    "drug_therapy_name": "GEMCITABINE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1735,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1Q",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 913,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1R",
    "pharmaceutical_therapy_type": "TCV",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 792,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2192,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1R",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "VACCINE",
    "days_to_drug_start": 1006,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2863,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1R",
    "pharmaceutical_therapy_type": "CANCERVAX",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2526,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 3349,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1R",
    "drug_therapy_name": "IL-2",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 3105,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1V",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1005,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1280,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA1W",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 761,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA1W",
    "pharmaceutical_therapy_type": "VACCINE",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1065,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1765,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.W3.AA21",
    "drug_therapy_name": "PACLITAXEL",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3075,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA21",
    "drug_therapy_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 3075,
    "pharmaceutical_tx_ongoing": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.W3.AA21",
    "pharmaceutical_therapy_type": "TCV",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1065,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 2100,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.WE.A8K5",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1823,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1860,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.A8K6",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 294,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.A8ZM",
    "drug_therapy_name": "DIPHENCYPRONE",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 2946,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.A8ZN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1533,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1618,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.WE.A8ZQ",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 1818,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.A8ZQ",
    "drug_therapy_name": "DABRAFENIB",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1853,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.A8ZR",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 261,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.AAA0",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 856,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 917,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.AAA0",
    "drug_therapy_name": "PEMBROLIZUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1166,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.AAA4",
    "drug_therapy_name": "MELPHALAN",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 360,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 360,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.AAA4",
    "drug_therapy_name": "VEMURAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 517,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 527,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.AAA4",
    "drug_therapy_name": "DABRAFENIB",
    "pharmaceutical_therapy_type.1": "CHEMOTHERAPY",
    "days_to_drug_start": 535,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.WE.AAA4",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 739,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.XV.A9W5",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 264,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.XV.AB01",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.YG.AA3O",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 1081,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.YG.AA3O",
    "drug_therapy_name": "INTERFERON",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 977,
    "pharmaceutical_tx_ongoing": false,
    "days_to_drug_end": 1006,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.YG.AA3P",
    "drug_therapy_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type.1": "IMMUNOTHERAPY",
    "days_to_drug_start": 385,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": false
  },
  {
    "patient_ID": "TCGA.Z2.A8RT",
    "pharmaceutical_therapy_type": "PHASE III TRIAL",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 722,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  },
  {
    "patient_ID": "TCGA.Z2.AA3V",
    "pharmaceutical_therapy_type": "PHASE III TRIAL",
    "pharmaceutical_therapy_type.1": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 228,
    "pharmaceutical_tx_ongoing": true,
    "therapy_on_clinical_trial": true
  }
]
